S

Secretome Therapeutics

HealthUnited States

Secretome Therapeutics is focused on developing regenerative cardiac therapies, particularly targeting conditions like Duchenne muscular dystrophy associated cardiomyopathy. The company aims to restore and regenerate cardiac function through innovative cellular therapies, with recent funding set to advance their clinical trials and manufacturing capabilities.

$30M · Series AVisit website ↗

Funding history

  1. $30MSeries A2026-05-28
    Source: news.google.com

Investors in Secretome Therapeutics

Backers from this company's tracked funding rounds.

  • RA Capital Management

More Health companies

Recently funded startups in the same category.

Related on Datapile